Stay updated on Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial page
- Check7 days agoChange DetectedThe page now shows Revision: v3.6.4, reflecting a minor system update to the record history interface. No study content or historical entries are modified.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedRevision: v3.6.3 is now shown, replacing Revision: v3.6.2 in the page footer. This indicates a routine update to the history-view interface of the study record.SummaryDifference0.0%

- Check36 days agoChange DetectedThe Revision tag on the History page was updated to v3.6.2, replacing the previous v3.6.0. This indicates a minor update to the page’s versioning rather than substantive changes to trial content.SummaryDifference0.0%

- Check43 days agoChange DetectedA new history entry dated 2026-06-17 adds Contacts/Locations and Study Status sections to the record. This also includes a related 2026-06-16 entry and a numeric value 100, indicating updates to the study history data.SummaryDifference0.2%

- Check50 days agoChange DetectedThe history now includes 'No longer looking for participants', indicating recruitment has ended. The record updates to Revision: v3.6.0, replacing Revision: v3.5.5 in the history.SummaryDifference0.2%

- Check58 days agoChange DetectedThe Record History now shows Revision: v3.5.5, replacing the prior v3.5.4. This reflects a small update to the page's version rather than changes to trial information.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial page.